Training program to promote diversity in cancer research

促进癌症研究多样性的培训计划

基本信息

项目摘要

Summary Disparities in cancer incidence and mortality rates among different ethnic/racial groups has been well recognized; however, research in this area has lagged behind, partly due to a shortage of cancer researchers and physicians from underrepresented minorities. North Carolina is among the most diverse states in the nation, and ranks ninth with respect to African American population. African Americans, Hispanics/Latinos, and Native Americans are 33% of the state's population. Accordingly, there is obvious cancer disparity. Thus, we created the “North Carolina Summer Undergraduate Prostate Cancer Research Program (NC-SUPR)” which offers summer research experiences to undergraduates from two local HBCUs. The program was supported by the Department of Defense for the last two years, and successfully implemented. Based on this fruitful experience, we have arranged a larger consortium of “Cancer Equity Research Training at North Carolina (CERT-NC)” by four Universities, including two local HBCUs. We now propose to create a new R25 training program for promoting diversity of cancer research at Wake Forest Baptist Comprehensive Cancer Center (WFBCCC). The objective of this training program is to promote and enhance diversity of the future cancer research workforce, by providing undergraduates from under-represented populations with opportunities for short-term research experiences. Our Specific Aims are to: (i) Recruit highly qualified underrepresented minority undergraduates through CERT-NC and nationwide; (ii) Engage participants in hands-on research activities in basic and translational laboratories and expose them to cutting-edge cancer research; (iii) Provide mentorship and guidance to participants for their career development; and (iv) Guide students in future career development and track their progress. Our proposed program includes multiple innovative approaches. First, it will build on the experience of the successful NC-SUPR program, while expanding its scope. Second, the program will use the unique consortium, CERT-NC, which consists of WFBCCC, two local HBCUs, and another regional college with a large enrollment of Native Americans. Third, we will implement the “Ambassador program”, which provides students with community outreach experience. Fourth, the program's distinguished faculty will provide education so that participants achieve a grasp of cancer biology basics and learn about state-of-the-art technologies for precision medicine and drug development. Fifth, the program offers career guidance from underrepresented minority faculty as “Career mentors”. Lastly, the program will be strengthened by interactions with other summer research programs at Wake Forest University. Thus, participants will interact with other underrepresented minority students and establish peer networks for future career development. Our program features faculty committed to mentorship and a diverse scientific environment with exposure to cutting-edge approaches to cancer biology, and can implement proven methods for recruitment and follow-up for efficient and effective administration of a vibrant training program.
概括 不同民族/种族群体之间癌症发病率和死亡率的差异很大 然而,这一领域的研究却相对滞后,部分原因是癌症研究人员的短缺。 北卡罗来纳州是美国最多元化的州之一。 国家,在非裔美国人、西班牙裔/拉丁裔和非裔美国人人口中排名第九。 美洲原住民占该州人口的 33%,因此,存在明显的癌症差异。 创建了“北卡罗来纳州暑期本科生前列腺癌研究计划(NC-SUPR)” 为来自两个当地 HBCU 的本科生提供暑期研究经验。 国防部近两年来,并在此基础上成功实施并取得丰硕成果。 根据经验,我们安排了一个更大的“北卡罗来纳州癌症公平研究培训”联盟 (CERT-NC)”由四所大学(包括两所当地 HBCU)发起 我们现在建议创建新的 R25 培训。 维克森林浸信会综合癌症中心促进癌症研究多样性的计划 (WFBCCC)该培训计划的目标是促进和增强未来癌症的多样性。 研究人员,为来自代表性不足的人群的本科生提供机会 我们的具体目标是: (i) 招募高素质的代表性不足的人。 通过 CERT-NC 和全国范围的少数民族本科生; (ii) 让参与者参与实践研究; (iii) 在基础和转化实验室提供活动,让他们接触前沿的癌症研究; 为参与者的职业发展提供辅导和指导;以及 (iv) 指导学生未来的职业发展; 我们提出的计划包括多种创新方法。 将借鉴 NC-SUPR 计划的成功经验,同时扩大其范围。 计划将使用独特的联盟 CERT-NC,该联盟由 WFBCCC、两个本地 HBCU 和 另一所拥有大量美国原住民的地区大学 第三,我们将实施 “大使计划”,为学生提供社区外展体验。 教师将提供卓越的教育,使参与者掌握癌症生物学基础知识和 了解精准医学和药物开发的最先进技术第五,该计划。 最后,该计划将由代表性不足的少数族裔教师作为“职业导师”提供职业指导。 通过与维克森林大学其他夏季研究项目的互动而得到加强。 参与者将与其他代表性不足的少数族裔学生互动,并为未来建立同伴网络 我们的项目以致力于指导和多元化科学的教师为特色。 接触癌症生物学尖端方法的环境,并且可以实施经过验证的方法 用于招聘和后续工作,以高效和有效地管理充满活力的培训计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN J. KRIDEL其他文献

STEVEN J. KRIDEL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN J. KRIDEL', 18)}}的其他基金

Training program to promote diversity in cancer research
促进癌症研究多样性的培训计划
  • 批准号:
    10450628
  • 财政年份:
    2018
  • 资助金额:
    $ 12.55万
  • 项目类别:
Training program to promote diversity in cancer research
促进癌症研究多样性的培训计划
  • 批准号:
    9999521
  • 财政年份:
    2018
  • 资助金额:
    $ 12.55万
  • 项目类别:
Training program to promote diversity in cancer research
促进癌症研究多样性的培训计划
  • 批准号:
    10680399
  • 财政年份:
    2018
  • 资助金额:
    $ 12.55万
  • 项目类别:
NAD+ metabolism in prostate cancer
前列腺癌中的 NAD 代谢
  • 批准号:
    9036948
  • 财政年份:
    2012
  • 资助金额:
    $ 12.55万
  • 项目类别:
NAD+ metabolism in prostate cancer
前列腺癌中的 NAD 代谢
  • 批准号:
    8657918
  • 财政年份:
    2012
  • 资助金额:
    $ 12.55万
  • 项目类别:
NAD+ metabolism in prostate cancer
前列腺癌中的 NAD 代谢
  • 批准号:
    8508894
  • 财政年份:
    2012
  • 资助金额:
    $ 12.55万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7146332
  • 财政年份:
    2006
  • 资助金额:
    $ 12.55万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7658128
  • 财政年份:
    2006
  • 资助金额:
    $ 12.55万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7895851
  • 财政年份:
    2006
  • 资助金额:
    $ 12.55万
  • 项目类别:
Fatty acid synthase inhibitors and prostate cancer
脂肪酸合酶抑制剂与前列腺癌
  • 批准号:
    7280912
  • 财政年份:
    2006
  • 资助金额:
    $ 12.55万
  • 项目类别:

相似海外基金

DULCE (Diabetes InqUiry Through a Learning Collaborative Experience)
DULCE(通过学习协作体验进行糖尿病查询)
  • 批准号:
    10558119
  • 财政年份:
    2023
  • 资助金额:
    $ 12.55万
  • 项目类别:
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
  • 批准号:
    10557638
  • 财政年份:
    2023
  • 资助金额:
    $ 12.55万
  • 项目类别:
Identifying the Effects of Race-Related Stressors on Laboratory- Induced Stress and Craving among African Americans with Alcohol Use Disorder
确定种族相关压力源对患有酒精使用障碍的非裔美国人实验室诱发的压力和渴望的影响
  • 批准号:
    10664454
  • 财政年份:
    2023
  • 资助金额:
    $ 12.55万
  • 项目类别:
Enhancing Mentoring of Diverse Early Career Researchers
加强对多元化早期职业研究人员的指导
  • 批准号:
    10797836
  • 财政年份:
    2023
  • 资助金额:
    $ 12.55万
  • 项目类别:
Implementation and Implications of Sickle Cell Trait Screening in the NCAA
镰状细胞性状筛查在 NCAA 中的实施及其意义
  • 批准号:
    10842764
  • 财政年份:
    2023
  • 资助金额:
    $ 12.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了